Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin
Amber de Haan(University Medical Center Groningen), Martin H. de Borst(University Medical Center Groningen), Andrea B. Kramer(Martini Ziekenhuis), Constantijn Konings(Radboud University Nijmegen), Ewout J. Hoorn(Erasmus MC), T.C. Rothuizen(Rijnstate Hospital), Liffert Vogt(Amsterdam Neuroscience), Joris I. Rotmans(Leiden University Medical Center), Femke Waanders, Mark Eijgelsheim(Erasmus MC), Albertien M. van Eerde(Hospital Reina Sofía de Murcia), Aaltje Y Adema(Medisch Centrum Leeuwarden), H. Siebe Spijker(Leiden University Medical Center), Gijs Fortrie(Groene Hart Ziekenhuis), Bert van der Zwaag(University Medical Center Utrecht), Roos F. Marsman(Amsterdam Neuroscience), Joan Doornebal(Isala), Nine Knoers(University Medical Center Utrecht), Laura R. Claus(University Medical Center Utrecht)
Cited by 9
Related Papers
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Intensive Care Medicine|2014|1k
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|European Journal of Endocrinology|2014|823
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|708
Clinical practice guideline on diagnosis and treatment of hyponatraemia
|Nephrology Dialysis Transplantation|2014|555
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration
|Nephrology Dialysis Transplantation|2020|411